Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 807 items.
TEVA-ECTOSONE: Presence of contaminant (degradant) in affected lot.
RecallHealth product recall | 2024-06-21
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
RecallHealth product recall | 2024-06-14
Unauthorized sexual enhancement products may pose serious health risks
AlertPublic advisory | 2024-06-13
Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
RecallHealth product recall | 2024-06-10
PMS-PIRFENIDONE 267 & 801 mg: Data integrity concerns with products bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-07
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
AlertHealth professional risk communication | 2024-06-07
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns
AlertPublic advisory | 2024-06-07
Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06
Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-06
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
AlertHealth professional risk communication | 2024-06-05
Jamp Digoxin tablet: Over-sized tablet
RecallHealth product recall | 2024-06-03
Fake Viagra and Cialis drugs seized from Petro Canada in Vineland, ON
AlertPublic advisory | 2024-05-31
Unauthorized sexual enhancement products may pose serious health risks (March 21, 2023 to May 27, 2024)
AlertPublic advisory | 2024-05-27
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16